Denna buys AVNR 5.41: Avanir Pharmaceuticals Reports Fiscal 2014 Third Quarter Financial and Business Update
ALISO VIEJO, Calif., Aug. 5, 2014 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today reported financial results for the three and nine months ended June 30, 2014. Quarterly Financial Highlights Total company net revenues of $28.6 million. ...
23 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home